Target intelligence / Profile preview

Eukaryotic translation initiation factor 3 subunit E pseudogene 2 (EIF3EP2)

Target
EIF3EP2
Molecular classification
Other (Pseudogene)
01

Overview

EIF3EP2, or eukaryotic translation initiation factor 3 subunit E pseudogene 2, is classified as a **pseudogene**, meaning it is a DNA sequence derived from the functional EIF3E gene but typically does not encode a functional protein. Unlike the canonical EIF3E gene—which encodes a component of the eukaryotic initiation factor 3 complex essential for protein synthesis and is involved in pathways regulating translation, cell proliferation, and has known disease associations—pseudogenes such as EIF3EP2 are generally considered **nonfunctional** and are not recognized as therapeutic targets or druggable entities[2]. There is no evidence supporting a distinct biological function, disease role, or clinical relevance for EIF3EP2 itself. **Key Notes:** - The entry relates to a **pseudogene**, not to the functional EIF3E gene or the eIF3 protein complex[2]. - Some pseudogenes can act as non-coding RNAs or have regulatory functions, but there is no direct evidence for such a role for EIF3EP2 in the available data[2]. - **EIF3E** (the functional gene) is involved in translation and cancer biology as part of the eIF3 complex, but these functions do **not apply** to EIF3EP2[1][3]. - EIF3EP2 does **not** have known clinical or therapeutic significance. If your intention was to refer to the functional, protein-coding gene EIF3E (eukaryotic translation initiation factor 3 subunit E), it is a distinct entity and would qualify for several of the information fields listed, but pseudogene 2 (EIF3EP2) does not.

Other names
EIF3EP2eukaryotic translation initiation factor 3, subunit E pseudogene 2eIF3e pseudogene 2

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 3 subunit E pseudogene 2 (EIF3EP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit E pseudogene 2 (EIF3EP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call